2025. Antiproliferative activity of the bioactive compound from Silybum marianum in a human melanoma cell line with BRAF mutation: potential for therapeutic repurposing. Revista Fitos. 19, (Jul. 2025), e1812. DOI:https://doi.org/10.32712/2446-4775.2025.1812.